Global Antibody Therapeutics and Blood Antibody Therapeutics Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Antibody Therapeutics and Blood Antibody Therapeutics will have significant change from previous year. According to our latest study, the global Antibody Therapeutics and Blood Antibody Therapeutics market size is USD million in 2022 from USD 187250 million in 2021, with a change of % between 2021 and 2022. The global Antibody Therapeutics and Blood Antibody Therapeutics market size will reach USD 371210 million in 2028, growing at a CAGR of 10.3% over the analysis period.
The United States Antibody Therapeutics and Blood Antibody Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibody Therapeutics and Blood Antibody Therapeutics market, reaching US$ million by the year 2028. As for the Europe Antibody Therapeutics and Blood Antibody Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibody Therapeutics and Blood Antibody Therapeutics players cover Roche, Abbvie, Johnson & Johnson, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Therapeutics and Blood Antibody Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
IgG1
IgG4
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Autoimmune
Tumor
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2017-2028
2.1.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antibody Therapeutics and Blood Antibody Therapeutics Segment by Type
2.2.1 IgG1
2.2.2 IgG4
2.2.3 Others
2.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
2.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Antibody Therapeutics and Blood Antibody Therapeutics Segment by Application
2.4.1 Autoimmune
2.4.2 Tumor
2.4.3 Others
2.5 Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
2.5.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2022)
3 Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Player
3.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Players
3.1.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Therapeutics and Blood Antibody Therapeutics by Regions
4.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth (2017-2022)
4.3 APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth (2017-2022)
4.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
5.2 Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
5.3 Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022)
6.2 APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
6.3 APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics by Country (2017-2022)
7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Antibody Therapeutics and Blood Antibody Therapeutics Forecast
10.1.3 APAC Antibody Therapeutics and Blood Antibody Therapeutics Forecast
10.1.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Forecast
10.1.5 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Forecast
10.2 Americas Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.2.2 Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.2.3 Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.2.4 Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.3 APAC Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Region (2023-2028)
10.3.1 China Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.3.2 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.3.3 Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.3.4 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.3.5 India Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.3.6 Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.4.2 France Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.4.3 UK Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.4.4 Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.4.5 Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.5 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.5.2 South Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.5.3 Israel Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.5.4 Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.5.5 GCC Countries Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast
10.6 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Type (2023-2028)
10.7 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Abbvie
11.2.1 Abbvie Company Information
11.2.2 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbvie Main Business Overview
11.2.5 Abbvie Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Information
11.7.2 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Alexion Pharmaceuticals Main Business Overview
11.7.5 Alexion Pharmaceuticals Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Biogen
11.10.1 Biogen Company Information
11.10.2 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Biogen Main Business Overview
11.10.5 Biogen Latest Developments
11. UCB
11.11.1 UCB Company Information
11.11.2 UCB Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 UCB Main Business Overview
11.11.5 UCB Latest Developments
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Information
11.12.2 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Eli Lilly and Company Main Business Overview
11.12.5 Eli Lilly and Company Latest Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Information
11.13.2 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
11.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 AstraZeneca Main Business Overview
11.13.5 AstraZeneca Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Antibody Therapeutics and Blood Antibody Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of IgG1
Table 3. Major Players of IgG4
Table 4. Major Players of Others
Table 5. Antibody Therapeutics and Blood Antibody Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Antibody Therapeutics and Blood Antibody Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Antibody Therapeutics and Blood Antibody Therapeutics Key Players Head office and Products Offered
Table 14. Antibody Therapeutics and Blood Antibody Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Antibody Therapeutics and Blood Antibody Therapeutics
Table 44. Key Market Challenges & Risks of Antibody Therapeutics and Blood Antibody Therapeutics
Table 45. Key Industry Trends of Antibody Therapeutics and Blood Antibody Therapeutics
Table 46. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Roche Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 53. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 54. Roche Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Abbvie Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 58. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 59. Abbvie Main Business
Table 60. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Abbvie Latest Developments
Table 62. Johnson & Johnson Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 63. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Johnson & Johnson Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. Novartis Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 73. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 74. Novartis Main Business
Table 75. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Novartis Latest Developments
Table 77. Merck Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 78. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 79. Merck Main Business
Table 80. Merck Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Merck Latest Developments
Table 82. Alexion Pharmaceuticals Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 83. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 84. Alexion Pharmaceuticals Main Business
Table 85. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Alexion Pharmaceuticals Latest Developments
Table 87. Takeda Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 88. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 89. Takeda Main Business
Table 90. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Takeda Latest Developments
Table 92. Amgen Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 93. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 94. Amgen Main Business
Table 95. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Amgen Latest Developments
Table 97. Biogen Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 98. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 99. Biogen Main Business
Table 100. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Biogen Latest Developments
Table 102. UCB Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 103. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 104. UCB Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. UCB Main Business
Table 106. UCB Latest Developments
Table 107. Eli Lilly and Company Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 108. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 109. Eli Lilly and Company Main Business
Table 110. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Eli Lilly and Company Latest Developments
Table 112. AstraZeneca Details, Company Type, Antibody Therapeutics and Blood Antibody Therapeutics Area Served and Its Competitors
Table 113. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product Offered
Table 114. AstraZeneca Main Business
Table 115. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. AstraZeneca Latest Developments
List of Figures
Figure 1. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type in 2021
Figure 7. Antibody Therapeutics and Blood Antibody Therapeutics in Autoimmune
Figure 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market: Autoimmune (2017-2022) & ($ Millions)
Figure 9. Antibody Therapeutics and Blood Antibody Therapeutics in Tumor
Figure 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market: Tumor (2017-2022) & ($ Millions)
Figure 11. Antibody Therapeutics and Blood Antibody Therapeutics in Others
Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Antibody Therapeutics and Blood Antibody Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Antibody Therapeutics and Blood Antibody Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Antibody Therapeutics and Blood Antibody Therapeutics Market Size 2023-2028 ($ Millions)
